Glenmark Life Sciences IPO Reviews, Dates, Price Band, Market Lot & Financial Details 2021

The Glenmark Life Sciences IPO will hit the market soon, and you can apply for the IPO from 27th July to 29th July 2021. Glenmark Life Sciences is planning to raise ₹1,513.60 Crores through an IPO which consists of fresh issue of ₹1,060 crores worth equity and OFS (Offer For Sale) of 6,300,000 equity shares by Glenmark Pharmaceuticals.

Glenmark Life Sciences manufactures quality drugs in the field of API ( Active Pharmaceutical Ingredients). It is an API subsidiary of Glenmark Pharmaceuticals Limited. They have created very strong relationships with the world’s leading pharmaceutical companies, which helped them grow rapidly. Globally, they supply their products to 540 pharmaceutical companies. Major exports are done in Latin America, Japan, Europe, North America, and the rest of the world. Many IPOs are going to launch this year check here the list.

Glenmark Life Sciences IPO Dates & Price Band:

Open date27th July 2021
Close date29th July 2021
Total Size of IPO₹1,513.60 Cr.
Fresh Issue 1,060 Cr.
Offer for Sale6,300,000 equity shares
Price Band₹695 – 720
Face Value₹2 per share
Listing onNSE and BSE
Retail Investor’s Portion35%

Glenmark Life Sciences IPO Market Lot:

The minimum market lot of Glenmark Life Sciences IPO is 13 shares with 14,400 applications. Retail investors can apply for 13 lots with 260 shares application worth 1,87,200.

ApplicationLotSharesCut Off Amount
Minimum (RII)12014,400
Maximum (NII)132601,87,200

Objectives of Issue – 

  • To make a payment of all the borrowings.
  • To finance capital expenditure for upcoming projects.
  • To meet general corporate purposes.

Should you subscribe to Glenmark Life Sciences IPO?

We have researched and mentioned the strengths and risks of the Glenmark Life Sciences IPO. The final verdict will help you make the right decision.

Strength – 

  • Leading producer of APIs for chronic therapeutics like pain management, CVS, and CNS. 
  • Export products in Latin America, Japan, Europe, North America and the rest of the world. 
  • Strong relationships with the world’s leading pharmaceutical companies.
  • Quality product manufacturing with the 
  • Promising financial track record.

Risks – 

  • Suspension, Slowdown or decrease in availability of material can cause harm to financial numbers. 
  • Increase in cost of raw materials can cause a huge impact on their operating profits. 
  • Failure to meet the standard norms of Indian Government or International Government can be a major risk to their products.

Final Verdict – 

They are Leading producers of APIs for chronic therapeutics like pain management, CVS, and CNS. In a short span of time, Glenmark Life Sciences have achieved rapid growth due to their strong connections and quality production. They export to 540 pharma companies worldwide which shows they have a large versatile client base. As an investor, this gives us the confidence to bet on Glenmark Life Sciences.

Investors can invest for the long term in the Glenmark Life Sciences IPO. It’s early to predict but Glenmark Life Sciences IPO can give great listing gains by seeing its grey market premium. You can keep a track of Glenmark Life Sciences IPO GMP here.

Glenmark Life Sciences IPO Allotment & Listing Dates:

Glenmark Life Sciences IPO’s open date is 27th July and the closing date is 29th July. Allotment of shares will be done on 3rd August and the listing date on NSE & BSE is 6th August 2021.

Allotment Date for Glenmark Life Sciences – 3rd August 2021
Refund Date for Glenmark Life Sciences – 4th August 2021
Credit of Shares to Demat Account – 5th August 2021
Listing Date for Glenmark Life Sciences – 6th August 2021

Applying IPO through the form: 

Besides applying IPOs through ASBA application or through Demat accounts you can also apply to IPOs with the help of forms provided by NSE or BSE. This is one of the traditional and safe ways to apply for an IPO subscription. Download the form through this link and fill the form carefully. You have to submit your filled form to the bank or broker.

Financials of Glenmark Life Sciences IPO:

The financials of Glenmark Life Sciences are very attractive. From 2019 the revenue numbers are increasing constantly. Net income is also increasing slightly. Upcoming financial numbers are expected to be good so we suggest investors apply for the IPO.

YearRevenue (₹ in Cr.)Expense (₹ in Cr.)PAT Net Income (₹ in Cr.)
2019886.87658.59195.59
2020 1549.301128.4313.10
2021 1418.471088.15246.89

About Glenmark Life Sciences:

Glenmark Life Sciences is an API arm of Glenmark Pharmaceuticals Limited. They work with top 16 pharmaceutical firms globally and bring the creativity and operating efficiency to meet the customer needs. In total they have 120 APIs in their portfolio. 

Their massive production and research facilities allow them to deliver the best services. They are Leading producers of APIs for chronic therapeutics like pain management, CVS, and CNS. Having strong connections with other pharma companies has helped us to export our products to Latin America, Japan, Europe, North America and the rest of the world.

Competitor’s Comparison –

Sr.No.Company NamePE 
1Divi’s Laboratories Ltd72.9
2Laurus Labs Ltd18.21
3Shilpa Medicare Ltd19.62
4Aarti Drugs Ltd11.65
5Solara Active Pharma Sciences Ltd33.24

IPO Registrar Details –

KFin Technologies Private Limited 
Selenium Tower-B
Plot No-31 and 32, Financial District
Nanakramguda, Serilingampally
Hyderabad, Rangareddi 500032
Telangana, India
Tel: +91 40 6716 2222
E-mail: [email protected]

Glenmark Life Sciences Contact Details –

Glenmark Life Sciences Limited
Registered Office:
Plot No. 170-172, Chandramouli Industrial Estate,
Mohol Bazarpeth, Solapur 413 213, Maharashtra
Corporate Office:
Glenmark House, B. D. Sawant Marg,
Andheri (East), Mumbai 400099,
Maharashtra, India
Tel: +912189 234456/ +912189 234246
Website: www.glenmarklifesciences.com

Glenmark Life Sciences IPO FAQs –


When will Glenmark Life Sciences IPO open for Investors?

Glenmark Life Sciences IPO will open on 27th July 2021 and will close on 29th July 2021.

What is Glenmark Life Sciences IPO Retail Portion?

The portion allocated for retail investors in Glenmark Life Sciences IPO is 35%

How to apply for Glenmark Life Sciences IPO?

You can apply Glenmark Life Sciences IPO in 3 ways:
Open a Demat account through a bank or brokerage firm and apply through it.
Apply via ASBA application online through your bank.
Fill up the offline IPO form and submit it to the bank or broker.

Should I invest in Glenmark Life Sciences IPO?

They are Leading producers of APIs for chronic therapeutics like pain management, CVS, and CNS. In a short span of time, Glenmark Life Sciences have achieved rapid growth due to their strong connections and quality production. They export to 540 pharma companies worldwide which shows they have a large versatile client base. As an investor, this gives us the confidence to bet on Glenmark Life Sciences.

What is the allotment date for Glenmark Life Sciences shares?

3rd August 2021 is the allotment date for Glenmark Life Sciences shares.

What is the listing date for Glenmark Life Sciences IPO?

6th August 2021 is the listing date for Glenmark Life Sciences. It will be listed on NSE and BSE.

What is the cutoff price for Glenmark Life Sciences IPO?

The cutoff price for Glenmark Life Sciences IPO is ₹720 per share.

Will Glenmark Life Sciences IPO give listing gains?

Investors can invest for the long term in Glenmark Life Sciences. It’s early to predict but Glenmark Life Sciences can give great listing gains by seeing its grey market premium. You can keep a track of Glenmark Life Sciences IPO GMP here. 


Disclaimer for Investors:

  • We on ipogmp.in do not buy or sell any kind of IPO forms.  
  • Do not subscribe to IPO just by seeing its GMP. You should do proper research about the fundamentals of a company.
  • IPO GMP changes every day and you can view the changes in the above table.
  • Always apply to an IPO after understanding financials and discussing with your financial advisor.
Spread the love

Leave a Reply

Your email address will not be published. Required fields are marked *